Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Balanced designs for multiple crossover studies.

W Gaus1, J Högel

  • 1Biodesign-CRF, Institut für Klinische Pharmakologie, Freiburg, Fed. Rep. of Germany.

Arzneimittel-Forschung
|February 1, 1992
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Right ventricle dimensions and function in response to acute hypoxia in healthy human subjects.

Acta physiologica (Oxford, England)·2016
Same author

[Hawthorn extract WS 1442 in the treatment of patients with heart failure and LVEF of 25%-35%].

MMW Fortschritte der Medizin·2011
Same author

Clinical characterisation of 29 neurofibromatosis type-1 patients with molecularly ascertained 1.4 Mb type-1 NF1 deletions.

Journal of medical genetics·2010
Same author

The (-765 G→C) promoter variant of the COX-2/PTGS2 gene is associated with a lower risk for end-stage hip and knee osteoarthritis.

Annals of the rheumatic diseases·2010
Same author

Sample volume positioning in colour-coded Doppler myocardial imaging: effect of systolic and diastolic tracking.

Ultrasound in medicine & biology·2008
Same author

Benfotiamine in diabetic polyneuropathy (BENDIP): results of a randomised, double blind, placebo-controlled clinical study.

Experimental and clinical endocrinology & diabetes : official journal, German Society of Endocrinology [and] German Diabetes Association·2008
Same journal

Wirksamkeit und Verträglichkeit eines pflanzlichen Arzneimittels mit Kapuzinerkressenkraut und Meerrettich bei akuter Sinusitis, akuter Bronchitis und akuter Blasenentzündung im Vergleich zu anderen Therapien unter den Bedingungen der täglichen Praxis.

Arzneimittel-Forschung·2013
Same journal

Abstracts of the Paul-Martini-Stiftung Symposium 2012 in combination with the National Academy of Leopoldina. November 16-17, 2012. Berlin, Germany.

Arzneimittel-Forschung·2013
Same journal

Leave-one-out procedure in the validation of elimination rate constant analysis.

Arzneimittel-Forschung·2012
Same journal

Pharmacokinetic and myocardial enzyme profiles of two administration routes of epirubicin in breast cancer patients.

Arzneimittel-Forschung·2012
Same journal

Synthesis, anti-hypertensive effect of a novel angiotensin II AT1 receptor antagonist and its anti-tumor activity in prostate cancer.

Arzneimittel-Forschung·2012
Same journal

Effect of zeolite nano-materials and artichoke (Cynara scolymus L.) leaf extract on increase in urinary clearance of systematically absorbed nicotine.

Arzneimittel-Forschung·2012
See all related articles

This study introduces balanced crossover designs for experiments with multiple treatments and periods. It provides minimal case numbers and experimental plans for efficient, carry-over effect-minimized trials.

Area of Science:

  • Experimental Design
  • Biostatistics
  • Clinical Trials

Background:

  • Crossover designs are frequently used in research to compare multiple treatments within the same subjects.
  • Carry-over effects can confound results in sequential treatment administration.
  • Balancing experimental conditions is crucial for robust and interpretable outcomes.

Purpose of the Study:

  • To define and enumerate balanced crossover designs for experimental situations.
  • To minimize the influence of carry-over effects in sequential treatment trials.
  • To provide practical guidance on constructing efficient experimental plans.

Main Methods:

  • Consideration of experimental situations with 't' treatments, 'n' cases, and 'p' periods (p ≤ t).
  • Construction of designs adhering to three balance conditions: equal treatment per case, equal treatment per period, and equal transition frequency.

Related Experiment Videos

  • Determination of minimal case numbers for complete (p=t) and incomplete (p

    • Main Results:

    • The study provides the minimal number of cases required for balanced crossover designs.
    • Experimental plans (designs) are explicitly listed for minimal case numbers.
    • Applicable for 2 ≤ p ≤ t ≤ 10, covering a range of experimental complexities.

    Conclusions:

    • Balanced crossover designs ensure experimental integrity by mitigating carry-over effects.
    • The provided minimal case numbers and designs offer efficient solutions for researchers.
    • This work facilitates the planning of robust clinical trials and other experimental studies.